Healthcare Economics & Policy

The shareholders of both Centene and WellCare Health Plans have approved a plan for the two companies to merge, they announced June 24. The deal is worth $17.3 billion and is expected to close in the first half of 2020.

Healthcare stocks are reeling following an executive order from President Trump that would give HHS the ability to require hospitals and health insurance companies to provide patients with prices for healthcare services based on negotiated rates.

Two major, global pharmaceutical companies ––AbbVie and Allergan––are merging in a deal worth approximately $63 billion.

Arkansas, the first state to implement work requirements for certain Medicaid beneficiaries, isn’t seeing the promised benefit of increased employment as a result of the new rules, according to a recent report from The Commonwealth Fund.


Repealing the Affordable Care Act would have serious, immediate consequences, according to the Urban Institute, including 20 million more uninsured people.

Not-for-profit hospitals don’t pay taxes, but many of them act like Fortune 500 companies, taking on operations that mimic corporate giants.

Kaiser Permanente, the Oakland, California-based health system, is building a new headquarters in the same city. The new headquarters, which is called Kaiser Permanente Thrive Center and will accommodate 7,200 national and Northern California Region employees and physicians, comes with a price tag of about $900 million, according to the San Francisco Chronicle.

The sky-high costs of receiving medical care and the reality of asking for help to pay those bills are being highlighted by The Huffington Post in a series titled “Life and Death: Stories from Inside America’s GoFundMe Health Care System.”

The acquisition of Aetna by CVS Health, which came at a price tag of $69 billion and brought together the nation’s third-largest health insurance provider with one of the biggest pharmacy retailers and pharmacy benefit managers (PBMs), is at risk as the transaction is still under review by a court.

UnityPoint Health, a hospital network based in the Midwest, is stepping up to invest in digital health and healthcare services solutions with a new $100 million venture fund, UnityPoint Health Ventures Innovation Fund.

Drugmaker Pfizer hid that one of its powerful anti-inflammatory drugs for rheumatoid arthritis therapy, Enbrel, reduced the risk of Alzheimer’s disease by 64%, according to a report by the Washington Post.


Partners HealthCare, a Boston-based health system, has backed out of its planned acquisition of Care New England